Carbonyl group of aliphatic side chain of pentoxifylline does not play role for P-glycoprotein antagonizing effect of pentoxifylline

General Physiology and Biophysics

Volumn 21, Issue 4, 2002, Pages 471-478

  Kupsakova I ^a   Docolomansky P ^b   Rybar A ^a   Barancik M ^a   Breier, Albert ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

Author keywords

L1210 cells; Mdr1 gene product; Multidrug resistance; P glycoprotein; Pentoxifylline; Vincristine

Indexed keywords

BENZENE DERIVATIVE; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CALMODULIN INHIBITOR; CARBONYL DERIVATIVE; CORONARY VASODILATING AGENT; CYCLOSPORIN DERIVATIVE; DOXORUBICIN; GLYCOPROTEIN P; HORMONE; INDOLE ALKALOID; ISOBUTYLMETHYLXANTHINE; PENTOXIFYLLINE; QUINOLINE DERIVATIVE; SCHIFF BASE; THEOPHYLLINE; VINCRISTINE;

ANIMAL CELL; CELL SURVIVAL; CHEMICAL REACTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; INFRARED SPECTROSCOPY; LEUKEMIA L 1210; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; REVIEW;

ANIMALS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LEUKEMIA L1210; MICE; MOLECULAR CONFORMATION; P-GLYCOPROTEIN; PENTOXIFYLLINE; VINCRISTINE; XANTHINES;

ANIMALIA; PLEURONECTIDAE;

EID: 0037000017     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Avendano C., Menendez J. C. (2002): Inhibitors of multidrug resistance to antitumor agents (MDR). Curr. Med. Chem. 9, 159-193
2. Barančík M., Bohaáčová V., Kvačkajová J., Hudecová S., Križanová O., Breier A. (2001): SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. Eur. J. Pharm. Sci. 14, 29-36
3. Boháčová V., Kvačkajová J., Barančík M., Drobná Z., Breier A. (2000): Glutathione S-transferase does not play a role in multidrug resistance of L1210/VCR cell line. Physiol Res. (Prague) 49, 447-453
4. Breier A., Barančík M., Štefanková Z., Uhrík B., Tribulová N. (1994): Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line. Neoplasma 41, 297-303
5. Breier A., Drobná Z., Bohaáčová V., Barančík M. (1998): Resistance of L1210 mouse leukemic cell line characterized by overexpression of ATP dependent drug transporter to several drugs. Chem. Papers 52, (Sp. Issue) 418-419
6. Breier A., Drobná Z., Dočolomansky P., Barančík M. (2000): Cytotoxic activity of several unrelated drugs on L1210 mouse leukemic cell sublines with P-glycoprotein (PGP) mediated multidrug resistance (MDR) phenotype. A QSAR study. Neoplasma 47, 100-106
7. Drobná Z., Stein U., Walther W., Barančík M., Breier A. (2002): Pentoxifylline influences drug transport activity of P-glycoprotein and decreases mdrl gene expression in multidrug resistant mouse leukemic L1210/VCR cells. Gen. Physiol. Biophys. 21, 103-109
8. Ford J. M., Hait W. N. (1990): Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42, 155-199
9. Ford J. M., Hait W. N. (1993): Pharmacologic circumvention of multidrug resistance. Cytotechnology 12, 171-212
10. Gottesman M. M., Hrycyna C. A., Schoenlein P. V., German U. A. Pastan I. (1995): Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 29, 607-649
11. Higgins C. F. (1992): ABC transporters: from microorganisms to man. Annu. Rev. Cell. Biol. 8, 67-113
12. Chitnis M. P., Viladkar A. B., Juvekar A. S. (1990): Inhibition of DNA biosynthesis by vincristine and pentoxifylline in murine P388 leukemia cells resistant to doxorubicin. Neoplasma 37, 619-626
13. Juliano R. L., Ling V. (1976): A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta. 455, 152-162
14. Kišucaká J, Barančík M, Boháčová V, Breier A. (2001): Reversal effect of specific inhibitors of extracellular-signal regulated protein kinase pathway on P-glycoprotein mediated vincristine resistance of L1210 cells. Gen. Physiol. Biophys. 20, 439-44
15. Kvačkajová-Kišucká J., Barančík M., Breier A. (2001): Drug transporter and their role in multidrug resistance of neoplastic cells. Gen. Physiol. Biophys. 20, 215-237
16. Ling V. (1997): Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol. 40, (Suppl.) S3-8
17. Litman T., Druley T.E., Stein W.D., Bates S.E. (2001): From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 58, 931-959
18. Nielsen D., Skovsgaard T. (1992): P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines. Biochim. Biophys. Acta 1139, 169-183
19. Ojima I., Bounaud P. Y., Oderda C. F. (1998): Recent strategies for the treatment of multi-drug resistance in cancer cells. Expert Opin. Ther. Pat. 8, 1587-1598
20. Poleková L., Barančík M., Mrázová T., Pirker R., Wallner J., Sulová Z., Breier A. (1992): Adaption of mouse leukemia cells L1210 to vincristine. Evidence for expression of P-glycoprotein. Neoplasma 39, 73-77
21. Štefanková Z., Barančík M., Breier A. (1996): Overcoming of P-glycoprotein mediated vincristine resistance of L1210/VCR mouse leukemic cells could be induced by pentoxifyline but not by theophylline and caffeine. Neoplasma 43, 11-15
22. Viladkar A., Chintnis M. (1994): In vitro effects of pentoxifylline and doxorubicin on cell survival and DNA damage in sensitive and MDR-P388 leukemia cells. Cancer. Biother. 9, 143-151